Xylo Bio Advances XYL-1001 Phase 1 Trial in Major Depression
Boston, Massachusetts, U.S., September 15, 2026 Xylo Bio, a clinical-stage biotechnology company developing novel neurotherapeutics for psychiatric and neurological...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Boston, Massachusetts, U.S., September 15, 2026 Xylo Bio, a clinical-stage biotechnology company developing novel neurotherapeutics for psychiatric and neurological...
Irvine, California, U.S., September 15, 2026 Allergan Aesthetics, an AbbVie company, is preparing to advance scientific discussion around skin...
Miami, Florida, USA, September 2, 2026 Summit Therapeutics Inc. has reported that its partner Akeso Inc. achieved a statistically...
Tempe, Arizona, USA, September 2, 2026 GT Medical Technologies has announced Renown Regional Medical Center as the latest institution...
North Chicago, Illinois, USA, September 2, 2026 Allergan Aesthetics, an AbbVie company, has unveiled its new “Layered Beauty: The...
Yokneam Illit, Israel, September 2, 2026 PixCell Medical has expanded its international presence into Canada through a strategic partnership...
Hamburg, Germany, and Sydney, Australia, September 2, 2026 Evotec SE and Plectonic Biotech have entered into a research collaboration...
Irvine, California, USA, September 1, 2026 SkinMedica, part of Allergan Aesthetics, an AbbVie company, has expanded its regenerative skincare...
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
New York, New York, August 4, 2026 Nuvation Bio has announced that it will present new subgroup analyses from...
